WisdomTree BioRevolution Fund Rating $17.77 -0.62 (-3.37%) As of 06/5/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.69Holdings in WDNA have an aggregate rating of Moderate Buy based on 441 analyst ratings issued in the past year covering 24 companies (55.2% of the portfolio).WDNA Aggregate Price Target$17.77High Prediction$17.77Average Prediction$17.77Low Prediction$17.77Holdings in WDNA have an aggregate price target of $17.77 and a range of $17.77 to $17.77 covering 24 companies (55.2% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 WDNA Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.80%TWSTTwist Bioscience$69.22-6.4%1.282 of 5 stars2.75$58.00 -16.2%8News CoverageGap Down4.30%LLYEli Lilly and Company$1,133.15+0.7%4.1677 of 5 stars2.87$1,227.00 8.3%30Trending NewsAnalyst Forecast3.43%MRNAModerna$47.44-8.0%1.5423 of 5 stars1.83$35.73 -24.7%183.00%JNJJohnson & Johnson$232.81+2.0%4.3593 of 5 stars2.74$253.04 8.7%27Trending News2.78%UTHRUnited Therapeutics$549.87+0.4%4.3906 of 5 stars2.85$619.42 12.6%13Insider Trade2.42%DARDarling Ingredients$59.42-2.1%3.3026 of 5 stars2.92$69.00 16.1%13Positive News2.35%IMNMImmunome$18.58-5.6%3.6097 of 5 stars2.85$33.17 78.5%13News Coverage2.31%TEMTempus AI$46.43-11.2%3.0998 of 5 stars2.47$68.64 47.8%15News CoverageAnalyst ForecastGap Down2.24%BEAMBeam Therapeutics$29.40-10.5%2.1276 of 5 stars2.71$46.83 59.3%142.16%STOKStoke Therapeutics$30.01-0.4%2.856 of 5 stars2.73$41.83 39.4%11News Coverage2.13%NTRANatera$215.31-3.1%4.2032 of 5 stars2.81$256.12 19.0%21Analyst ForecastInsider Trade2.07%CRSPCRISPR Therapeutics$51.84-9.0%3.046 of 5 stars2.53$65.47 26.3%19News CoverageOptions Volume2.05%BGBunge Global$126.70-2.1%3.7012 of 5 stars2.91$132.67 4.7%112.04%CTVACorteva$77.06-0.5%3.7603 of 5 stars2.61$88.67 15.1%23Positive News1.98%IONSIonis Pharmaceuticals$74.48-0.9%3.2975 of 5 stars2.90$100.90 35.5%21News CoverageInsider Trade1.82%KRYSKrystal Biotech$301.00-2.2%2.9904 of 5 stars2.83$324.11 7.7%12Insider Trade1.78%TXG10x Genomics$31.04-7.3%1.5104 of 5 stars2.20$23.17 -25.4%15Positive NewsGap Down1.73%GILDGilead Sciences$129.160.0%4.8591 of 5 stars2.90$156.93 21.5%29Trending NewsInsider TradeHigh Trading Volume1.73%GPCRStructure Therapeutics$37.58-3.8%2.4265 of 5 stars2.89$109.25 190.7%19News Coverage1.65%AMGNAmgen$349.58+1.2%4.2608 of 5 stars2.48$353.81 1.2%31Trending NewsAnalyst Forecast1.64%TMOThermo Fisher Scientific$472.98-1.9%4.8761 of 5 stars2.92$613.67 29.7%24Positive NewsAnalyst Forecast1.62%ROIVRoivant Sciences$28.58-3.2%3.1446 of 5 stars2.75$33.59 17.5%12News CoveragePositive News1.61%PFEPfizer$26.04+1.4%3.5772 of 5 stars2.20$28.82 10.7%20Trending News1.57%RVMDRevolution Medicines$149.23-4.1%2.306 of 5 stars3.00$123.72 -17.1%22Analyst ForecastAnalyst Revision This page (BATS:WDNA) was last updated on 6/6/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredOne hidden supplier shipped 5 billion parts to SpaceXMost investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...Weiss Ratings | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredHow to get into the SpaceX IPO before June 12Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...Brownstone Research | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
